Peptides
AssigneeFaron Ventures Oy
InventorsElina Kivi, Kati Elima, Sirpa Jalkanen
Life of this patent
Estimating the term…
Abstract
This invention relates to novel peptides, discovered by using phage display technique, that bind to VAP-1 (Vascular Adhesion Protein-1). The invention concerns also peptides useful as VAP-1 ligands. Such peptides constitute a portion of natural proteins that are present in the individual. The invention relates particularly to a peptide chain in the leukocyte surface protein, where said peptide chain is useful as a ligand for the VAP-1 molecule and thus facilitates the binding of leukocytes to the vascular endothelium. Furthermore, the invention relates to pharmaceutical and diagnostic compositions for targeting VAP-1 in vivo.
Claims10
An isolated peptide having the amino acid sequence CVKWRGVVVC (SEQ ID NO. 1) or CWSFRNRVLC (SEQ ID NO. 2).
Dependencies are inferred from the claim text.